Colorectal Neoplasms, Hereditary Nonpolyposis: Clinical Trials

145 trials for Colorectal Neoplasms, Hereditary Nonpolyposis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

44 completed, 38 recruiting, 24 unknown, 14 active not recruiting. 52 Not applicable, 11 Phase 2, 6 Phase 1, 6 Phase 3, 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable52Completed 20, Recruiting 14, Unknown 8, Active not recruiting 3, Not yet recruiting 3, Enrolling by invitation 2, Terminated 1, Withdrawn 1
Phase 211Active not recruiting 3, Recruiting 3, Terminated 2, Completed 1, Not yet recruiting 1, Unknown 1
Phase 16Active not recruiting 2, Completed 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 36Active not recruiting 2, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Early Phase 14Completed 3, Terminated 1

Follow Colorectal Neoplasms, Hereditary Nonpolyposis: new trials by email Literature Review of Colorectal Neoplasms, Hereditary Nonpolyposis trials Research Report on Colorectal Neoplasms, Hereditary Nonpolyposis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Aiming to Test Whether Non-invasive Liquid Biopsies Can Safely Reduce Invasive Surveillance Methods in Lynch Syndrome
INVITRO DIAGNOSTIC TESTS AND COLONOSCOPY - Lynch Syndrome
Not applicableNot yet recruitingUNICANCER20002026-12-012026-08-03
Protocol for Non-invasive Gynaecological Surveillance in Lynch Syndrome
Lynch Syndrome
Not yet recruitingUniversity of Edinburgh14502026-10-162026-10-22
Preventive Dendritic Cell Vaccination for Lynch Syndrome Carriers
Arm A: DC vaccination, Arm B: Placebo vaccination - Lynch Syndrome
Phase 3Not yet recruitingRadboud University Medical Center3722026-10-012026-05-27
Preventive Dendritic Cell Vaccination for Lynch Syndrome
DC vaccination - Lynch Syndrome
Phase 1 / Phase 2Not yet recruitingRadboud University Medical Center162026-10-012026-08-19
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
VVD-133214, Pembrolizumab - Colorectal Adenocarcinoma
Phase 2RecruitingVividion Therapeutics, Inc.1402026-09-112026-10-21
Overcoming Barriers to Uptake of Cascade Screening
Let's Talk Genetics Providers, Let's Talk Patients - Lynch Syndrome
Not applicableNot yet recruitingUNC Lineberger Comprehensive Cancer Center202026-09-012026-08-26
A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families
Discussion, Internet-Based Intervention, Survey Administration - BRCA1-Related Hereditary Breast and Ovarian Cancer Syndrome, BRCA2-Related Hereditary Breast and Ovarian Cancer Syndrome
Not applicableNot yet recruitingUniversity of Michigan Rogel Cancer Center1502026-06-152026-05-19
Periodontal Disease in Patients With Lynch Syndrome
periodontal charting for the diagnosis of periodontitis - Lynch Syndrome, Periodontal Disease
Not yet recruitingRotundo Roberto252026-06-012026-05-22
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
educational workshop on nutrition + additional intervention on UPF tool and how to use it - Breast Cancer, Pancreas Cancer
Not applicableRecruitingGustave Roussy, Cancer Campus, Grand Paris1702026-05-042026-05-08
Evaluation of Capsule Colonoscopy in Patients With Lynch Syndrome
colon capsule endoscopy - Lynch Syndrome
Not yet recruitingRegion Skane782026-05-012026-04-30
Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome
Sampling of suspected skin lesions (in accordance with good care practices)., Constitution of a biobank - Basal Cell Carcinoma of Skin, Site Unspecified, Epidermoid Carcinoma
Not applicableRecruitingCentre Hospitalier Universitaire de Nīmes1502026-03-132026-06-22
Population Based Germline Testing for Early Detection and Prevention of Cancer
Genetic testing for Cancer Susceptibility Genes (CSGs) (BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2, MLH1, MSH2, MSH6) and personalised breast and ovarian cancer risk - Breast Cancer Risk, Ovarian Cancer Risk
Not applicableRecruitingQueen Mary University of London60002025-12-182026-03-27
The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract
Kidney sparing surgery for high-risk upper urinary tract urothelial carcinoma - Upper Urinary Tract Urothelial Carcinoma
RecruitingZealand University Hospital25002025-11-262025-12-22
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
Menstrual cup use - Endometrial Cancer, Lynch Syndrome
Not applicableRecruitingJessica D. St. Laurent, MD252025-11-202026-06-10
Clinical Validation of Sophia Genetics Assay
Sophia Herditary Cancer Solution - Ovarian Cancer, Breast Cancer
Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS2482025-09-152025-09-08
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
Information Letter and Booklet, Information Letter - Cascade Testing, Lynch Syndrome
Not applicableRecruitingUniversity of Alabama at Birmingham1852025-09-152026-07-21
First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers
Autologous Tolerogenic Dendritic cells - Lynch Syndrome
Phase 1RecruitingFundacion Clinic per a la Recerca Biomédica202025-09-042026-04-13
Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire
Vaginal DNA swab, microbiome swab and pH test - Endometrial Cancer, Lynch Syndrome
Not applicableRecruitingUniversity of British Columbia302025-08-292026-09-03
Using Visual Arrays to Support Understanding of Genetic Risk
Visual Array, Narrative Visual Array, Choice - Decision Aid
Not applicableCompletedStephanie B. Seminara, MD10452025-07-282026-09-24
FITting Non-invasive Tests in Lynch Syndrome Surveillance
Fecal immunochemical test - Colorectal Cancer
Not applicableRecruitingUniversity of Chicago4002025-07-102026-10-21

Showing 20 of 145. Sign in to see all of them.

Narrower conditions

Colorectal Neoplasms (38)  ·  Colonic Neoplasms (20)  ·  Endometrial Neoplasms (20)  ·  Hereditary Breast and Ovarian Cancer Syndrome (16)  ·  Neoplastic Syndromes, Hereditary (10)  ·  Ovarian Neoplasms (10)  ·  Turcot syndrome (10)  ·  Breast Neoplasms (9)  ·  Peutz-Jeghers Syndrome (9)  ·  Pancreatic Neoplasms (8)  ·  Adenomatous Polyposis Coli (7)  ·  Neoplasms (6)  ·  Prostatic Neoplasms (6)  ·  Rectal Neoplasms (6)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (145)  ·  Neoplasms by Site (145)  ·  Digestive System Diseases (144)  ·  Digestive System Neoplasms (144)  ·  Gastrointestinal Diseases (144)  ·  Gastrointestinal Neoplasms (144)  ·  Intestinal Diseases (144)  ·  Intestinal Neoplasms (144)  ·  Metabolic Diseases (144)  ·  Nutritional and Metabolic Diseases (144)  ·  Colonic Diseases (143)  ·  DNA Repair-Deficiency Disorders (143)  ·  Genetic Diseases, Inborn (142)  ·  Neoplasms (139)  ·  Neoplastic Syndromes, Hereditary (135)

Interventions

Surveys and Questionnaires (10)  ·  Colonoscopy (6)  ·  Specimen Handling (6)  ·  Biopsy (4)  ·  Genetic Testing (4)  ·  Observation (4)  ·  Endoscopy (3)  ·  Genetic Counseling (3)  ·  High-Throughput Nucleotide Sequencing (3)  ·  Interviews as Topic (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Nivolumab (3)  ·  Aspirin (2)  ·  Educational Status (2)  ·  Mesalamine (2)

Sponsors

M.D. Anderson Cancer Center (10)  ·  National Cancer Institute (NCI) (8)  ·  Assistance Publique - Hôpitaux de Paris (5)  ·  University Health Network, Toronto (4)  ·  Geisinger Clinic (3)  ·  Kaiser Permanente (3)  ·  Lei Li (3)  ·  Ohio State University Comprehensive Cancer Center (3)  ·  Radboud University Medical Center (3)  ·  San Raffaele University (3)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2)  ·  Fox Chase Cancer Center (2)  ·  Hospital Clinic of Barcelona (2)  ·  Institute of Cancer Research, United Kingdom (2)  ·  Johns Hopkins University (2)

Countries

United States (71)  ·  France (12)  ·  United Kingdom (12)  ·  Netherlands (11)  ·  Italy (10)  ·  Canada (8)  ·  China (7)  ·  Denmark (5)  ·  Puerto Rico (4)  ·  Spain (4)  ·  Sweden (4)  ·  Germany (3)  ·  Israel (3)  ·  Belgium (2)  ·  Finland (2)

Top investigators

Eduardo Vilar-Sanchez (2)  ·  Giulia Martina Cavestro, MD, PhD (2)  ·  Jan H Kleibeuker, MD PhD (2)  ·  Jan J Koornstra, MD PhD (2)  ·  Karen H. Lu, MD (2)  ·  Karen M Basen-Engquist (2)  ·  Lei Li, MD (2)  ·  Megan Roberts, PhD (2)  ·  Paul Goodfellow (2)  ·  Raymond Kim, MD (2)  ·  Zsofia Stadler, MD (2)  ·  Adam H Buchanan, MS, MPH, CGC (1)  ·  Aimee Lucas, MD, MS (1)  ·  Ajay Bansal (1)  ·  Alexey Tsukanov, PhD (1)

Results publications

PMID 15951961, PMID 16632260, PMID 17682000, PMID 20142594, PMID 20181032, PMID 20379742, PMID 20733131, PMID 20840664, PMID 21212064, PMID 22062356, PMID 23254892, PMID 23451840, PMID 23825568, PMID 24484606, PMID 24916333, PMID 25047061, PMID 25209657, PMID 25833335, PMID 28107763, PMID 29802810, PMID 30538291, PMID 30730411, PMID 31028782, PMID 31197699, PMID 31307542, PMID 31498154, PMID 31520613, PMID 31537406, PMID 31666284, PMID 31676359, PMID 32414353, PMID 32641470, PMID 32887653, PMID 32958357, PMID 33161160, PMID 33984519, PMID 34086597, PMID 34149034, PMID 34678156, PMID 35689290, PMID 35705312, PMID 36670100, PMID 36946440, PMID 37025481, PMID 37027812, PMID 37099777, PMID 37126135, PMID 37516165, PMID 37760576, PMID 37787643

NIH funding

2025 (2), P30CA016672 (2), UG1CA242609 (2), 1KL2TR002490-01 (1), 2016 (1), 2018 (1), K01CA255137 (1), N01CN00034 (1), P30CA015704 (1), P30CA060553 (1), P30CA068485 (1), P50CA134254 (1), P50HD104224 (1), R00CA277584 (1), R01CA071754 (1)